Prebiotic supplementation over a cold season and during antibiotic treatment specifically modulates the gut microbiota composition of 3-6 year-old children.


Journal

Beneficial microbes
ISSN: 1876-2891
Titre abrégé: Benef Microbes
Pays: Netherlands
ID NLM: 101507616

Informations de publication

Date de publication:
19 Apr 2019
Historique:
pubmed: 20 2 2019
medline: 8 8 2019
entrez: 20 2 2019
Statut: ppublish

Résumé

Supplementing kindergarten children during a cold season with a prebiotic inulin-type fructans product with shorter and longer fructan chains has been shown to reduce febrile episodes requiring medical attention and to lower the incidence of sinusitis. These beneficial effects may be connected to the specific modulation of children's gut microbiota. By applying quantitative and qualitative microbiota analysis this study aimed at characterising the gut microbiota composition and at exploring effects of prebiotic intervention on the gut microbiota during a 24-weeks intervention and during antibiotic treatment in healthy children. The study was a randomised, placebo-controlled trial with 258 healthy children aged 3 to 6 years consuming 6 g/day prebiotic inulin-type fructans or maltodextrin. During the course of the study, faecal samples were collected and subject to targeted qPCR analysis and phylogenetic profiling by multiplexed high throughput sequencing of the prokaryotic 16S rRNA gene PCR amplicons. The microbiota composition of the cohort could be clustered into three distinct constellations (enterotypes). Prebiotic intake resulted in a selective modulation of the gut microbiota composition. Relative abundance of

Identifiants

pubmed: 30776899
doi: 10.3920/BM2018.0116
doi:

Substances chimiques

Anti-Bacterial Agents 0
Fructans 0
Polysaccharides 0
Prebiotics 0
RNA, Ribosomal, 16S 0
maltodextrin 7CVR7L4A2D
Inulin 9005-80-5

Banques de données

ClinicalTrials.gov
['NCT03241355']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Pagination

253-263

Auteurs

S Soldi (S)

1 AAT - Advanced Analytical Technologies Srl, Via P. Majavacca 12, 29017 Fiorenzuola d'Arda, Italy.

S Vasileiadis (S)

2 Department of Biochemistry & Biotechnology, University of Thessaly, Viopolis, 41500 Larissa, Greece.

S Lohner (S)

3 Department of Paediatrics, Clinical Center of the University of Pécs, Medical School, University of Pécs, József Attila u. 7, 7623 Pécs, Hungary.

F Uggeri (F)

1 AAT - Advanced Analytical Technologies Srl, Via P. Majavacca 12, 29017 Fiorenzuola d'Arda, Italy.

E Puglisi (E)

4 Microbiology Institute, Università Cattolica del Sacro Cuore in Piacenza, Via Emilia Parmense 84, 29122 Piacenza, Italy.

P Molinari (P)

4 Microbiology Institute, Università Cattolica del Sacro Cuore in Piacenza, Via Emilia Parmense 84, 29122 Piacenza, Italy.

E Donner (E)

5 Future Industries Institute (FII), Mawson Lakes Campus, University of South Australia, 5095 Mawson Lakes, Australia.

C Sieland (C)

6 Beneo-Institute, c/o Beneo GmbH, Wormser Straβe 11, 67283 Obrigheim, Germany.

T Decsi (T)

3 Department of Paediatrics, Clinical Center of the University of Pécs, Medical School, University of Pécs, József Attila u. 7, 7623 Pécs, Hungary.

M Sailer (M)

6 Beneo-Institute, c/o Beneo GmbH, Wormser Straβe 11, 67283 Obrigheim, Germany.

S Theis (S)

6 Beneo-Institute, c/o Beneo GmbH, Wormser Straβe 11, 67283 Obrigheim, Germany.
7 Beneo-Institute, c/o Beneo GmbH, Wormser Straβe 11, 67283 Obrigheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH